EISENBERG OR (Chief Financial Officer) received a stock award from NEUROSENSE THERAPEUTICS LTD.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/1/2026ACC: 0001213900-26-038545
Officer· Chief Financial Officer
Since Mar 2026
+200K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
200K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+200K
Price / share
—
Trade value
—
% of position
19.0%
3/26/2026
1.05M→1.25M
Total
Net shares
+200K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/26/2026 | A · Award | +200K | — | — | 19.0% | 1.05M | 1.25M |
| Total | +200K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported